Does Clonazepam (Klonopin) Withdrawal Cause Weight Gain or Weight Loss?

Does clonazepam (Klonopin) withdrawal cause weight gain?

It can. It can also cause weight loss, and loss is the only one of the two that the drug’s label lists among its withdrawal signs. The same label lists both increased appetite and loss of appetite, and “weight loss or gain,” among its adverse reactions.

The Ashton Manual, written by Professor C. Heather Ashton, describes the withdrawal side. In Chapter III, she wrote that considerable loss of weight, 8 to 10 pounds or more, sometimes occurs in withdrawal, and that some people gain weight instead. In her words, weight changes “are not severe enough to worry about and normal weight is soon regained after withdrawal.”

So, the honest answer has two directions and one rule. Weight may go up or down during a clonazepam taper, the change is usually modest and temporary, and it is never a reason to taper faster. Is the weight a sign of something the person is doing wrong?

Gaining weight during a taper is not a failure of willpower.

Unfortunately, much of what is written on this subject treats the person tapering as someone with a habit to control. It talks about emotional eating and unhealthy coping, as if the weight were a flaw of character. That is the addiction frame, and it does not fit.

Most people who taper clonazepam took it exactly as prescribed, often for years, for panic, anxiety, or seizures. Physical dependence is not addiction. In fact, dependence is the nervous system’s ordinary adaptation to a drug that was there every day, and it develops at prescribed doses.

When the dose comes down, that adaptation has to unwind slowly, and appetite, sleep, digestion, and energy are all caught up in it. A change on the scale during those months is not weakness. It is physiology.

What does the Klonopin label say about appetite and weight?

The Klonopin prescribing information seems to argue with itself. Among gastrointestinal reactions it lists anorexia, the medical word for loss of appetite, and a few words later, increased appetite. Among miscellaneous reactions it lists “weight loss or gain.”

The panic disorder section tells the same story. Decreased appetite appears in the table of trial results, and weight increase, weight decrease, and increased appetite all sit among the events the label calls infrequent. The drug can move appetite and weight in either direction, in different people, and not very often.

The label covers withdrawal as well. Since the 2020 boxed warning update from the United States Food and Drug Administration (FDA), it has listed weight loss and decreased appetite, along with nausea, vomiting, and diarrhea, among the acute withdrawal signs.

Yet, what the label leaves out matters too. It describes no slowing of metabolism, and it lists no effect on blood sugar or insulin. Those ideas circulate widely, and the label supports neither.

Why do some people lose weight in clonazepam withdrawal?

Because eating becomes hard. Nausea, an unsettled and bloated gut, and anxiety all take the appetite away. “Appetite/weight change” has its own line in Table 1 of Chapter III, the Manual’s list of withdrawal symptoms.

Professor Ashton suggested a second cause, a rebound effect on appetite. She noted that benzodiazepines increase appetite in animals, so a falling dose may briefly do the reverse.

Patients call the gut symptoms benzo belly. Weight lost this way tends to come back as the symptoms settle.

Why do other people gain weight?

For reasons that are just as ordinary. Appetite often returns with force once the nausea eases, and a person who ate little for weeks may eat a great deal for a while. That is a rebound, and it passes.

Sleep is usually broken during a taper, and most people know that a short night makes for a hungry day. Of course, anxiety plays its part as well. Some people cannot eat when they are anxious, and others eat to calm down.

Activity falls too. Fatigue and muscle pain keep a person on the couch through the hard stretches. The label also reports drowsiness far more often on clonazepam than on placebo, so for some people the extra weight may have arrived during the years on the drug.

Add bloating and constipation, which change the number on the scale without adding body fat. Is any of this a reason to change the taper? No.

Weight is never a reason to speed up a taper, or to stop one.

A taper is not a weight-loss plan, and a few pounds in either direction are not a signal to hurry. Think of a pendulum that has been held off to one side for years. Let it go slowly and it drifts a little past center, comes back, and settles.

Let it go all at once and it swings hard. Appetite behaves the same way when clonazepam is withdrawn. The answer to an unwelcome swing is never to let go faster.

The label’s boxed warning makes the same point in firmer language. Abrupt discontinuation or rapid dosage reduction “may precipitate acute withdrawal reactions, which can be life-threatening,” and the label names seizures among them. Call 911 for a seizure or any medical emergency.

Fortunately, the taper that protects the nervous system also gives appetite the best chance to settle. Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, builds clonazepam tapers on the Ashton Manual and the Maudsley Deprescribing Guidelines. The Manual suggests reductions of up to one tenth of the dose at each step, with the patient in control of the pace.

The Maudsley guidelines add the shape, with each step smaller than the last as the dose gets lower. The whole process takes months, sometimes longer. A dose can be held whenever symptoms, nausea and appetite among them, need time to settle.

Is clonazepam a good drug to taper from directly?

It is better than some and not as good as one. Clonazepam is longer acting than alprazolam (Xanax) or lorazepam (Ativan). Table 1 in the Manual’s opening chapter gives it a half-life of 18 to 50 hours, against 6 to 12 hours for alprazolam and 10 to 20 for lorazepam.

Yet, the Manual does not treat clonazepam as a drug to switch onto. In Chapter II, Professor Ashton observed that some doctors move patients to clonazepam for that purpose, and she called it “far from ideal.” It is an extremely potent drug, she wrote, and it is eliminated much faster than diazepam (Valium).

In the opening chapter’s Table 1, clonazepam is about twenty times as potent as diazepam, milligram for milligram. Diazepam is the Manual’s substitution drug, and both of its clonazepam schedules, Schedules 5 and 6, replace clonazepam with diazepam in stages before the slow reduction begins.

In Chapter II, Professor Ashton also acknowledged that some people have particular difficulty switching from Klonopin to diazepam. So, the crossover taper to diazepam is used where it helps, and other patients complete a Klonopin taper on clonazepam itself, in small steps. That choice is made between patient and doctor, and weight has no vote in it.

What helps with eating and movement during a taper?

Plain things, mostly. Chapter III of the Manual has a section on diet, fluids, and exercise, and its advice is deliberately unexciting. A normal healthy diet with plenty of fruit and vegetables, a source of protein, and not too much sugar or junk food provides what a person needs.

So, regular meals with some protein and fiber help, even small ones, on the days when appetite is gone. Fluids can follow thirst, since the Manual sees no need to drink extra. The Manual also recommends regular moderate exercise, and a daily walk counts, with no target to hit.

The middle of a taper is a poor time for a crash diet or a fast. Any large change in eating is a question for the patient’s own physician.

Weight-loss products and supplements are decided for each patient with a physician who understands the pharmacology. The Manual sees no general need for supplements in withdrawal, the evidence for any of them is limited, and people respond differently.

None of this treats withdrawal. Food, movement, and a regular bedtime support the person who is doing the tapering, and that is enough to ask of them. The article on nutrition during benzodiazepine withdrawal covers food in more detail.

When does weight change need a doctor’s attention?

Professor Ashton’s reassurance covers the usual case, not every case. A prescriber should hear about weight that is falling quickly, vomiting that keeps food or fluids from staying down, or eating that has all but stopped.

Dehydration is the practical danger there. It is a medical problem, and it should not be waited out.

A history of disordered eating belongs in the conversation before the taper starts. Loss of appetite can quietly restart old patterns of restriction, and a returning appetite can frighten a person who has struggled with food. A doctor who knows the history can watch for both.

And, weight that keeps climbing or falling long after a dose change deserves an ordinary medical evaluation. Not everything that happens during a taper is caused by the taper.

What else do patients ask about clonazepam and weight?

Is the answer different for Xanax, Ativan, or Valium?

No. The Ashton Manual describes weight change as a feature of benzodiazepine withdrawal in general, and it does not rank the drugs by their effect on weight. So, the same answer holds for Xanax, Ativan, and Valium.

It also holds for chlordiazepoxide, the benzodiazepine in Librax, a bowel medication that many people take without knowing what it contains. Weight may move in either direction, and it is never a reason to hurry.

What differs is the taper. Alprazolam and lorazepam wear off between doses, which is why the Manual advises a switch to diazepam for them. The general picture is covered in a separate article on weight gain and weight loss during a benzodiazepine taper.

Will weight return to normal after a clonazepam taper?

Usually, yes. The Manual says normal weight is soon regained after withdrawal, and the Klonopin label places weight loss and decreased appetite among the acute withdrawal signs, not among the protracted ones. Nobody can promise a date, because appetite follows sleep and digestion, and those take their own time.

A slow, supervised taper answers the weight question too.

Dr. Leeds’ practice offers one service, medically supervised benzodiazepine and z-drug tapering, on a concierge basis. Care starts with informed consent, which means the risks first, the alternatives, an exit plan, and the right to decline. The taper itself is gradual and patient directed, with a crossover to diazepam where it helps.

In Dr. Leeds’ practice, weight and appetite are discussed along the way, like sleep and anxiety, and they never set the pace. Patients in Florida who take clonazepam and want to come off it slowly will find a physician who does not hurry the process. Contact Dr. Leeds to ask about a taper plan.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.